Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(40.0%)
Early Phase 1
2(40.0%)
Phase 3
1(20.0%)
5Total
N/A(2)
Early Phase 1(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT00536185Not ApplicableCompleted

Heart & Health Study

Role: collaborator

NCT06064162Early Phase 1Completed

Ketamine for MS Fatigue

Role: lead

NCT03185169Early Phase 1Terminated

GSM (Genitourinary Syndrome Of Menopause) Management In Breast Cancer Survivors

Role: lead

NCT00658034Phase 3Unknown

Acupuncture for the Treatment of Chronic Post-Chemotherapy Fatigue

Role: lead

NCT00208039Not ApplicableCompleted

Pilot Trial of Surfactant Booster Prophylaxis For Ventilated Preterm Neonates

Role: collaborator

All 5 trials loaded